𝔖 Bobbio Scriptorium

✦ LIBER ✦

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

✍ Scribed by Roach, M.

Book ID: 125504495
Publisher: American Society of Clinical Oncology
Year: 2003
Tongue: English
Weight: 104 KB
Volume: 21
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2003.05.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III trial comparing whole-pelvic v

Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413: Roach M 3rd, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ, Rotman M, Jones C, Asbell SO, Valicenti RK, Han S, Thomas CR Jr, Shipley WS; Radiation Therapy Oncology Group 9413, University of California-San Francisco, San Francisco, CA. J Clin Oncol 2003;21:1904–1911

✍ Joseph A Smith 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 15 KB

Radiation Therapy Oncology Group (RTOG)

Radiation Therapy Oncology Group (RTOG) 9413: A Randomized Trial Comparing Whole Pelvic Radiation Therapy (WPRT) to Prostate Only (PORT) and Neoadjuvant Hormonal Therapy (NHT) to Adjuvant Hormonal Therapy (AHT)

✍ Roach, M.; Hunt, D.; Lawton, C.A.; Hsu, I.; Lustig, R.A.; Seider, M.; Christophe 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Radiation Therapy Oncology Group 0521: A

Radiation Therapy Oncology Group 0521: A Phase III Randomized Trial of Androgen Suppression and Radiation Therapy Versus Androgen Suppression and Radiation Therapy Followed by Docetaxel/Prednisone for Localized, High-Risk Prostate Cancer

✍ Asmita R. Patel; Howard M. Sandler; Kenneth J. Pienta 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 873 KB

Phase III Trial of Long-Term Adjuvant An

Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92-02

✍ Hanks, G. E. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 377 KB

Phase III trial of long-term adjuvant an

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02: Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU, Radiation Therapy Oncology Group, Fox Chase Cancer Center and Radiation Therapy Oncology Group, Phialdelphia, PA

✍ Michael Zelefsky 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 21 KB

An update of the Phase III trial compari

An update of the Phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13 with emphasis on unexpected hormone/radiation interactions: Lawton CA, DeSilvio M, Roach M III, Uhl V, Kirsch R, Seider M, Rotman M, Jones C, Asbell S, Valicenti R, Hahn S, Thomas CR Jr., Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI.

✍ Joycelyn L. Speight 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB